Immunogenicity and SARS-CoV-2 Infection following the Fourth BNT162b2 Booster Dose among Health Care Workers

Immunogenicity and SARS-CoV-2 Infection following the Fourth BNT162b2 Booster Dose among Health Care Workers

Introduction: The fourth SARS-CoV-2 vaccine dose was found to protect against infection and more importantly against severe disease and death. It was also shown that the risk of symptomatic or severe disease was related to the antibody levels after vaccination or infection, with lower protection aga...

Descripció completa

Dades bibliogràfiques
Autors principals: Yael Shachor-Meyouhas, Halima Dabaja-Younis, Avi Magid, Ronit Leiba, Moran Szwarcwort-Cohen, Ronit Almog, Michal Mekel, Avi Weissman, Gila Hyams, Vardit Gepstein, Nethanel A. Horowitz, Hagar Cohen Saban, Jalal Tarabeia, Michael Halberthal, Khetam Hussein
Format: Article
Idioma:English
Publicat: MDPI AG 2023-01-01
Col·lecció:Vaccines
Matèries:
COVID-19
Immunogenicity
serology
health care workers
booster
Accés en línia:https://www.mdpi.com/2076-393X/11/2/283

Internet

https://www.mdpi.com/2076-393X/11/2/283

Ítems similars